Welcome to the e-CCO Library!

P291: Effect of the preconception steroid-free remission period on disease activity during pregnancy and birth outcomes in women with Ulcerative Colitis: a retrospective cohort study
Year: 2022
Source: ECCO'22
Authors: Ikeda, A.(1);Kunisaki, R.(1);Aoki, S.(2);Yaguchi, K.(1);Asami, S.(1);Furusawa, K.(1);Atsusaka, R.(1);Azuma, D.(1);Tsunoda, S.(1);Fujii, K.(1);Nishida, D.(1);Madarame, A.(1);Nishio, M.(1);Ogashiwa, T.(1);Nakamori, Y.(1);Fuse, M.(1);Daibo, S.(1);Araki, K.(1);Kimura, H.(1);Suzuki, R.(3);Go, H.(4);Saigusa, Y.(4);Maeda, S.(5);
Created: Friday, 11 February 2022, 3:52 PM
P291: Improvements in access to IBD care following the implementation of a novel tiered triage model
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Wilson*1, D. Loomes1,2

Created: Friday, 22 February 2019, 9:41 AM
P291: Long term outcomes of children with ulcerative colitis after acute severe colitis: a multicenter study from the GETAID pédiatrique group
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pigneur, B.(1)*;Cochet, M.(1);Delphine , L.(2);Coopman, S.(2);Raphael , E.(3);Thierry, L.(3);Claire , D.(4);Stéphanie , W.(5);Rémi , D.L.(6);Georges , D.(7);Valérie, B.(8);Anne, B.(9);Christine, M.(10);Jerome, V.(10);Frank, R.(11);Julie, L.(12);
Created: Friday, 14 July 2023, 11:05 AM
P291: Pharmacokinetics, safety, and tolerability of etrasimod (APD334) in subjects with mild, moderate, or severe hepatic impairment: a single-dose, open-label, parallel-group study
Year: 2021
Source: ECCO'21 Virtual
Authors: Lee, C.(1);Tang, Y.(1);Schroeder, C.(1);Zhang, J.(1);Nguyen-Cleary, T.(1);Mullin, S.(1);Ma, M.(1); Lyon, N.(1);Grundy, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P291: Proteinase 3-antineutrophil cytoplasmic antibodies (PR3-ANCA) would be a predictive biomarker for the clinical course of ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sono M., Yoshino T., Yazumi S.

Created: Wednesday, 20 February 2019, 10:36 AM
P291: Sacroiliitis is under-recognised in inflammatory bowel disease and is associated with previous arthritis and inflammatory Crohn’s phenotype
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

O. Kelly*1, N. Li1, J. Chan2, R. Inman2, M. Silverberg1

Created: Friday, 22 February 2019, 9:49 AM
P292 Inflammatory bowel disease and their implications in Roma ethnicity: A preliminary study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

B. Castro1, M.J. García García1, M. Pascual1, J.L. Fernández-Forcelledo2, J. Crespo1, M. Rivero1

Created: Thursday, 30 January 2020, 10:12 AM
P292: Association of golimumab trough concentrations during maintenance with endoscopic and histologic remission in patients with ulcerative colitis.
Year: 2022
Source: ECCO'22
Authors: Taxonera Samso, C.(1);Fernández-Aceñero, M.J.(2);Olivares, D.(1);Calvo, M.(3);Casis, B.(4);Bermejo, F.(5);López Serrano, P.(6);Iborra, M.(7);Mesonero, F.(8);Boscá Watts, M.(9);Díaz del Arco, C.(2);Vera, I.(3);Olivares, S.(4);Alba, C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P292: Complications in elderly-onset Inflammatory Bowel Diseases – A population-based study from the epidemiological database of the Israeli IBD Research Nucleus (Epi-IIRN)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ben Hur, D.(1)*;Lebedenko, B.(2);Issaschar, G.(3);Moshe, R.(3);Lujan, R.(4);Focht, G.(4);Loewenberg Weisband, Y.(5);Kariv, R.(6);Ledderman, N.(7);Matz, E.(8);Dotan, I.(9);Turner, D.(4);Pinto, G.(3);Waterman , M.(1);
Created: Friday, 14 July 2023, 11:05 AM
P292: Development of a predictive model for the diagnosis of Crohn’s disease when ileocolonoscopy is insufficient: a multicentre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Boal Carvalho*1, M. Marques2, B. Rosa1, H. Cardoso2, F. Machado3, G. Macedo2, J. Cotter1, 4, 5

Created: Friday, 22 February 2019, 9:49 AM
P292: Effect of drug therapy on the lipid profiles of patient with Inflammatory Bowel Disease: a systematic review and meta-analysis
Year: 2021
Source: ECCO'21 Virtual
Authors: Sleutjes, J.A.M.(1);Roeters van Lennep , J.E.(2);Boersma , E.(3);de Vries , A.C.(1);van der Woude , C.J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P292: Faecal calprotecin may be a good predictor of histologic remission in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Knezevic Ivanovski1*, S. Knezevic Usaj2, P. Svorcan1, M. Nedeljkovic Protic1

Created: Thursday, 21 February 2019, 9:14 AM
P292: Immunomodulator and biological therapy are increased in inflammatory bowel disease patients with associated immune-mediated inflammatory diseases
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. J. Garcia Garcia*1, M. Pascual Mato1, C. Del Pozo Calzada1, L. Rasines Perez1, B. Castro Senosiain1, J. Crespo Garcia1, M. Rivero Tirado1

Created: Friday, 22 February 2019, 9:41 AM
P292: Perianal disease: far beyond a simple feature of Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Xavier S.*1, Gonçalves T.1, Castro F.1, Magalhães J.1, Moreira M.1, Cotter J.1,2,3

Created: Wednesday, 20 February 2019, 10:36 AM
P293 Loss of response after first-line biologic therapy in patients with inflammatory bowel disease: practical approach and management
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Busacca, B. Scrivo, E. Giuffrida, L. Guida, L. Carrozza, V. Calvaruso, M. Cappello

Created: Thursday, 30 January 2020, 10:12 AM
P293: Correlation between clinical measures to capture disease burden and prediction of the initial course of Crohn's disease - findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Attauabi, M.(1,2)*;Madsen, G.R.(2,3);Bendtsen, F.(2,3);Bjerrum, J.T.(1);Wilkens, R.(4);Theede, K.(2,3);Ilvemark, J.F.K.F.(2,3);Boysen, T.(2,3);Seidelin, J.B.(1);Burisch, J.(2,3);
Created: Friday, 14 July 2023, 11:05 AM
P293: Delayed timing of post-operative colonoscopy within 1 year does not predict a more severe Rutgeerts score
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Singh*1, J. Pang2, 3, C. Seow1, 2, 4, Y. Leung1, 2, 4, K. Novak1, 2, 4, R. Panaccione1, 2, 4, G. Kaplan1, 2, 3, 4

Created: Friday, 22 February 2019, 9:49 AM
P293: Histological risk factors to predict clinical relapse in ulcerative colitis in mucosal healing
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ozaki R.*1, Kobayashi T.1, Saito E.1, Toyonaga T.1, Okabayashi S.1, Umeda S.1, Nakano M.1, Matsuoka K.1, Morinaga S.1, Hisamatsu T.2, Hibi T.1

Created: Wednesday, 20 February 2019, 10:36 AM
P293: Influence of initial albumin levels on infliximab and adalimumab trough levels in inflammatory bowel disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Gonzalez-Lopez1, C. Llamas2, J.M. Giráldez-Montero1, R. Ferreiro3, I. Baston3, M.J. Lamas1, J.E. Dominguez-Munoz3, M. Barreiro-de Acosta3*

Created: Thursday, 21 February 2019, 9:14 AM
P293: Insights from patients with Ulcerative Colitis on disease burden: Findings from a real-world survey in Europe
Year: 2022
Source: ECCO'22
Authors: BurischPhD, J.(1,2);Hart, A.(3);Oortwijn, A.(4);Khalid, J.M.(4);Hennessy, F.(5);Knight, H.(5);Meadows, R.(5);Patel, H.(6);Armuzzi, A.(7);
Created: Friday, 11 February 2022, 3:52 PM